Format

Send to

Choose Destination
PLoS One. 2013 Nov 19;8(11):e80755. doi: 10.1371/journal.pone.0080755. eCollection 2013.

N (6)-substituted AMPs inhibit mammalian deoxynucleotide N-hydrolase DNPH1.

Author information

1
Institut Pasteur, Unité de Chimie et Biocatalyse, Paris, France ; CNRS, UMR3523, Paris, France ; Université Paris Descartes Sorbonne Paris Cité, Paris, France.

Erratum in

  • PLoS One. 2014;9(1). doi:10.1371/annotation/c529909c-9d88-4c03-9262-ff5c61b96a36.

Abstract

The gene dnph1 (or rcl) encodes a hydrolase that cleaves the 2'-deoxyribonucleoside 5'-monophosphate (dNMP) N-glycosidic bond to yield a free nucleobase and 2-deoxyribose 5-phosphate. Recently, the crystal structure of rat DNPH1, a potential target for anti-cancer therapies, suggested that various analogs of AMP may inhibit this enzyme. From this result, we asked whether N (6)-substituted AMPs, and among them, cytotoxic cytokinin riboside 5'-monophosphates, may inhibit DNPH1. Here, we characterized the structural and thermodynamic aspects of the interactions of these various analogs with DNPH1. Our results indicate that DNPH1 is inhibited by cytotoxic cytokinins at concentrations that inhibit cell growth.

PMID:
24260472
PMCID:
PMC3834327
DOI:
10.1371/journal.pone.0080755
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center